Premier Health of America Inc. finalizes a restructuring transaction as part of its proceedings under the *Companies' Creditors Arrangement Act* (CCAA). The transaction supports debt restructuring and operational adjustments amid financial challenges. The company had earlier announced plans for restructuring in alignment with creditor agreements.
Premier Health of America Inc. secures court approval for a restructuring transaction. The move enables the company to maintain uninterrupted operations during the process. The restructuring aims to stabilize financial and operational continuity.
Premier Health of America files for creditor protection under Canada’s Companies’ Credential Arrangement Act (CCAA) while maintaining uninterrupted operations. The company continues its core services during the restructuring process, ensuring no disruption to patients or partners.
Premier Health of America has filed for Companies' Creditors Arrangement Act (CCAA) proceedings to restructure operations. The move follows financial challenges affecting the healthcare provider’s ability to meet obligations. The filing aims to develop a restructuring plan while maintaining essential services for patients.
Premier Health of America Inc. terminates forbearance agreements with its principal lenders while maintaining its strategic review process. The move follows ongoing financial and operational assessments as the company evaluates long-term sustainability and potential restructuring options. No specific details on restructuring plans or financial outcomes have been disclosed.
Premier Health’s subsidiary, the Canadian Health Care Agency, secures multiple contracts totaling **$23 million**. The agreements expand its healthcare service offerings in Canada, though specific services or clients remain undisclosed. The contracts reflect growing demand for outsourced healthcare solutions in the region.
Premier Health of America
Premier Health of America was a Canadian provider of outsourced healthcare services to governments, companies, and individuals using proprietary LiPHe.